Streetbeat News

Analyst Ratings

CRL

Charles River (NYSE:CRL) received mixed analyst ratings in the last quarter with 2 bullish, 2 somewhat bullish, and 4 indifferent ratings. The average 12-month price target from 8 analysts is $227.12, which is a 7.51% decrease from the previous target of $245.57. The high target is $275.00 and the low target is $205.00. Analysts derive their ratings from various sources including company calls, financial statements, and insider information.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:00 pm

LNW

Light & Wonder (NASDAQ:LNW) has received 4 bullish analyst ratings in the last quarter, with no neutral or bearish ratings. The average 12-month price target among these analysts is $91.5, with a high of $104.00 and a low of $86.00. This target represents a 10.68% increase over the past month. Analysts rate stocks based on detailed research and insights, though their advice may be subject to error.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:00 pm

IRDM

Analysts have consistently rated Iridium Comms (NASDAQ:IRDM) as bullish over the last quarter with 4 positive ratings. The average 12-month price target for IRDM is $58.75, which is a decrease from the previous target of $64.33. This suggests a potential downside of 8.67% from the earlier price target.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:00 pm

MPW

Medical Properties Trust (NYSE:MPW) has received mixed analyst ratings in the last quarter, with 3 somewhat bullish, 2 indifferent, and 3 somewhat bearish ratings. Over the past 3 months, 8 analysts have set a 12-month price target for MPW, with an average target of $7.31, a high of $10.00, and a low of $4.00. This average price target represents a 37.36% decrease from the previous average of $11.67. Analyst ratings are opinions based on financial analysis and are meant to provide guidance to investors.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:00 pm

CABA

Cabaletta Bio (NASDAQ:CABA) has received positive ratings from analysts in the last quarter, with 5 bullish and 3 somewhat bullish ratings, and no negative ratings. The average 12-month price target for CABA is $29.5, which is an 88.26% increase from the previous target of $15.67. The high target is $40.00 and the low target is $17.00.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:00 pm

BXSL

Blackstone Secured (NYSE:BXSL) received 4 analyst ratings in the last quarter, with 2 bullish and 2 somewhat bullish, and no bearish ratings. The average price target is $29.25, representing an implied upside from the current price of $27.65. This target has increased by 3.25% from the previous target of $28.33. Analyst ratings are derived from financial analysis and are used to provide guidance on stocks.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 3:00 pm

PRA

Truist Securities analyst Mark Hughes has maintained a Hold rating on ProAssurance (NYSE:PRA) and reduced the price target from $20 to $15 as reported on November 9, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:54 pm

EVLV

Cantor Fitzgerald analyst Brett Knoblauch has maintained an Overweight rating on Evolv Technologies (NASDAQ:EVLV) but reduced the price target from $9 to $8.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:54 pm

RBC

Truist Securities analyst Michael Ciarmoli has maintained a Buy rating on RBC Bearings (NYSE:RBC) but lowered the price target from $275 to $271.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:53 pm

TMCI

Truist Securities analyst Richard Newitter has maintained a Buy rating on Treace Medical Concepts (NASDAQ:TMCI) but lowered the price target from $17 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:53 pm